NeoALTTO-open-paren-a-close-paren-_2A: NeoALTTO(a), figure 2A

NeoALTTO(a)_2AR Documentation

NeoALTTO(a), figure 2A

Description

Kaplan-Meier digitized data from NeoALTTO(a), figure 2A (PMID 25130998). A reported sample size of 455 for a primary endpoint of pCR in breast cancer.

Usage

`NeoALTTO(a)_2A`

Format

A data frame of 303 observations and 3 variables:

time event time (in years)
event EFS event indicator (0: no event, 1: event)
arm treatment arms (l, t)

Source

de Azambuja E, Holmes AP, Piccart-Gebhart M, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. Lancet Oncol 2014; 15: 1137–46.

Examples

summary(`NeoALTTO(a)_2A`)

kmplot(`NeoALTTO(a)_2A`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.